42 results
8-K
EX-99.2
ABOS
Acumen Pharmaceuticals Inc
14 May 24
Acumen Pharmaceuticals Reports First Quarter 2024 Financial Results and Business Highlights
7:35am
PHARMACOLOGYSELECTIVITY After binding to neurons, AOs disrupt Long Term Potentiation (LTP) and cause pathologic increases in intracellular calcium
8-K
EX-99.1
ABOS
Acumen Pharmaceuticals Inc
14 May 24
Acumen Pharmaceuticals Reports First Quarter 2024 Financial Results and Business Highlights
7:35am
assets
Marketable securities, long-term
Right-of-use asset
Restricted cash
Property and equipment, net
Other assets
Total assets
LIABILITIES … liability, short-term
Operating lease liability, short-term
Total current liabilities
Operating lease liability, long-term
Debt, long-term
Total liabilities
8-K
EX-99.1
1o94v6udyvjw018v
26 Mar 24
Results of Operations and Financial Condition
7:42am
8-K
EX-99.1
1ldzr1hj
19 Mar 24
Corporate Presentation March 2024 1
8:05am
8-K
EX-99.1
q37mgg5cg9nkb0pt3tce
12 Jan 24
Corporate Presentation January 2024 1
8:42am
8-K
EX-99.1
7unfkz6
4 Dec 23
Corporate Presentation December 2023 1
7:45am
8-K
EX-99.1
mmr khk4chcx
13 Nov 23
Corporate Presentation November 2023 1
5:10pm
8-K
EX-99.1
rpgo9u
13 Nov 23
Acumen Pharmaceuticals Reports Third Quarter 2023 Financial Results and Business Highlights
7:20am
8-K
EX-99.2
u3wradk0ford tqh
8 Aug 23
Acumen Pharmaceuticals Reports Second Quarter 2023 Financial Results and Business Highlights
7:33am
8-K
EX-99.1
c8qex80t23m7ij4d72v7
8 Aug 23
Acumen Pharmaceuticals Reports Second Quarter 2023 Financial Results and Business Highlights
7:33am
424B5
qjt8vo6acw 7xih5s
20 Jul 23
Prospectus supplement for primary offering
4:11pm
424B5
8sytcd15g1 0cjbi9l8p
17 Jul 23
Prospectus supplement for primary offering
4:49pm
8-K
EX-99.2
zutjyds6
9 May 23
Acumen Pharmaceuticals Reports First Quarter 2023 Financial Results and Business Highlights
7:08am
8-K
EX-99.1
wbq 8ji4u1
9 May 23
Acumen Pharmaceuticals Reports First Quarter 2023 Financial Results and Business Highlights
7:08am